Treatment information should also be accessible to people with additional needs such as physical, sensory, or learning disabilities. Family and caregiver involvement should be considered, if appropriate. This CPG is designed to assist in managing or co-managing patients with HTN. Moreover, the patient population of interest for this CPG is patients with HTN who are eligible for care in the VA and DoD healthcare delivery systems and those who are in the community receiving care from community-based clinicians. It includes Veterans as well as deployed and non-deployed active duty Service, Guard, and Reserve Members and their dependents. E. Highlighted Features of this Clinical Practice Guideline The 2020 edition of the VA/DoD HTN CPG is the third update to the original CPG. It provides practice recommendations for the care of individuals with HTN as well as guidance for treatment. A particular strength of this CPG is the multidisciplinary stakeholder involvement from its inception, ensuring representation from the broad spectrum of clinicians engaged in the diagnosis and management of HTN. The framework for recommendations in this CPG considered factors beyond the strength of the evidence, including balancing desired outcomes with potential harms of the intervention, the potential for variation in patient values and preferences, and other considerations (e.g., resource use, subgroup considerations) as appropriate. Applicability of the evidence to VA/DoD populations was also taken into consideration. An algorithm accompanies the guideline to provide an overview of the recommendations in the context of the flow of patient care and to assist with training providers (see Algorithm section). The algorithm may be used to help facilitate translation of guideline recommendations into practice. F. Patient-centered Care VA/DoD CPGs encourage providers to use a PCC approach that is individualized based on patient needs, characteristics, and preferences. 